Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Treating ocular neovascularization

Treating ocular neovascularization

US Patent 10143703 · Granted Dec 4, 2018

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Modified Mullerian Inhibiting Substance (MIS) proteins and uses thereof for the 2025
Biomarkers for age-related macular degeneration2023
High-dose statins for age-related macular degeneration2023
High-dose statins for age-related macular degeneration2023
High-dose statins for age-related macular degeneration2022
High-dose statins for age-related macular degeneration2022
Modified Mullerian inhibiting substance (MIS) proteins and uses thereof for the 2021
Methods for treating ocular inflammatory disorders2020
Methods for treating ocular inflammatory disorders2020
Methods for treating diabetic neurotherapy2020
Methods for treating diabetic neurotherapy2020
Compositions for preserving photoreceptor cells, retinal pigment epithelial cell2020